Could nasal spray of 'love hormone' treat autism?

May 16, 2012 By Jenifer Goodwin, HealthDay Reporter
Could nasal spray of 'Love hormone' treat autism?
Preliminary study of 7 children saw more activity in 'social' areas of the brain.

(HealthDay) -- Children with autism given a squirt of a nasal spray containing the hormone oxytocin showed more activity in brain regions known to be involved with processing social information, a small study found.

Researchers and other experts stressed that the study was small, involving only seven children, that the kids were given just a single dose of and that they haven't yet studied whether the differences in the will translate into differences in the children's behavior.

And yet experts said they were hopeful that oxytocin, which is nicknamed the "love hormone" and is believed to be involved with romantic love and human bonding, will one day be used to treat problems with reading and social communications that mark the .

"These findings add to a growing body of evidence that points to oxytocin and oxytocin-based therapeutics as having great potential for addressing core in autism," said Robert Ring, vice president for translational research at Autism Speaks, who was not involved with the study.

For the study, researchers from Yale University and colleagues gave seven children either a nasal spray containing oxytocin or an inactive placebo on two occasions.

While having their brain activity measured using a functional MRI, the kids were then given a series of tests to measure their responses to social cues and situations.

Children given the oxytocin showed increased activity in areas of the "social" brain, including the , the temporal parietal junction, the and the superior temporal sulcus. Their brain activity looked much more like a typically developing child's brain activity, noted lead study author Ilanit Gordon, a postdoctoral research fellow at Yale.

"For these seven kids, it seems the oxytocin really enhances in regions that are very important to how we function in the social world," Gordon said.

The research was to be presented May 19 at the International Meeting for Autism Research in Toronto.

What, if any, role oxytocin plays in autism isn't clear, Gordon said, but it's been a tantalizing area of research. One small study from the 1990s found that people with autism tended to have lower blood levels of oxytocin, but those findings were never replicated, she said. More recent research found that people with autism are more likely to have a specific variation of a gene that codes for the oxytocin receptor, but what the variation means functionally isn't known.

In 2012, French researchers reported that people with high-functioning autism became more socially engaged after being given oxytocin.

And yet, there isn't nearly enough evidence to recommend parents seeking out oxytocin now, experts said.

"Although enormously interesting, these findings are not sufficient to warrant use of oxytocin in clinical practice for autism today," Ring said. "Rather, they give reason to be hopeful that down the road, the knowledge being generated by studies such as this can be translated into safe and effective medicines."

Gordon added that even if oxytocin is proven to be effective, parents shouldn't expect that autism symptoms will suddenly disappear. Instead, it's more likely that oxytocin could one day be used in conjunction with behavioral or other therapies, perhaps to enhance the ability of children to learn to pay attention to social cues.

The study is ongoing and will eventually include 40 kids aged 7 to 18, according to Gordon.

The data and conclusions of research presented at medical meetings should be viewed as preliminary until published in a peer-reviewed journal.

Explore further: Can one model the social deficits of autism and schizophrenia in animals?

More information: The U.S. National Institutes of Health has more on autism.

Related Stories

Can one model the social deficits of autism and schizophrenia in animals?

May 5, 2011
5 May 2011 - The use of animal models to study human disease is essential to help advance our understanding of disease and to develop new therapeutic treatments.

The dark side of Oxytocin

August 1, 2011
For a hormone, oxytocin is pretty famous. It’s the “cuddle chemical”—the hormone that helps mothers bond with their babies. Salespeople can buy oxytocin spray on the internet, to make their clients trust ...

Recommended for you

Signaling pathway may be key to why autism is more common in boys

October 17, 2017
Researchers aiming to understand why autism spectrum disorders (ASD) are more common in boys have discovered differences in a brain signaling pathway involved in reward learning and motivation that make male mice more vulnerable ...

Whole genome sequencing identifies new genetic signature for autism

October 12, 2017
Autism has genetic roots, but most cases can't be explained by current genetic tests.

Mum's immune response could trigger social deficits for kids with autism

October 10, 2017
The retrospective cohort study of 220 Australian children, conducted between 2011-2014, indicates that a "an immune-mediated subtype" of autism driven by the body's inflammatory and immunological systems may be pivotal, according ...

Largest study to date reveals gender-specific risk of autism occurrence among siblings

September 25, 2017
Having one child with autism is a well-known risk factor for having another one with the same disorder, but whether and how a sibling's gender influences this risk has remained largely unknown.

Faulty cell signaling derails cerebral cortex development, could it lead to autism?

September 20, 2017
As the embryonic brain develops, an incredibly complex cascade of cellular events occur, starting with progenitors - the originating cells that generate neurons and spur proper cortex development. If this cascade malfunctions ...

Predicting atypical development in infants at high risk for autism?

September 12, 2017
New research from the Sackler Institute for Developmental Psychobiology at Columbia University Medical Center (CUMC) identifies a potential biomarker that predicts atypical development in 1- to 2-month-old infants at high ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet May 20, 2012
This appears to ignore the evolution of the hypothalamic neurogenic niche that links odors directly to social bonds, as in the mother-infant bond directly linked via food odors and social odors to sexually dimorphic brain development during the first three years of life. If anyone attempted to first learn the origins of the neuronal systems that depend on hypothalamic gonadotropin releasing hormone (GnRH), they might begin to wonder why autism spectrum disorders seem to develop during the same time frame and why they affect males more than females. Could the sex differences be merely coincidental?

So long as we have oxytocin, and dopaminergic / serotoninergic neuronal systems proposed to be responsible for cause and effect, others will probably continue to miss the direct effect of olfactory/pheromonal input on GnRH and everything else about the development of our evolved brain and typical and atypical behaviors.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.